Lapatinib is a cancer medication used together with capecitabine (Xeloda) or letrozole (Femara) to treat a certain type of advanced breast cancer that has spread to other parts of the body. Lapatinib is often given after other
cancer medications have been tried without successful treatment of symptoms.
Lapatinib Ditosylate
Specifications
Human
Oral
Commercial
FEATURED Products
Related Media
New Product Development
Where our FDA approved laboratory begins developing products, formulating and validating methods to ensure quality.
Compliance Audits
Where we audit and champion our partner factories to exceed cGMP standards set by authorities.
Regulatory Services
Where all submissions are filed with the knowledge and experience of our 550+ worldwide approvals on record.